- GoBroad Healthcare Group

Свяжитесь с нами

Chicago 2025 China Summit Successfully Concludes: Chinese Research Shines on ASCO Stage, Resonating with the Global Oncology Community

2025-6-6
Посмотреть
GHG Medical Team to Present Three Innovative Studies at ASCO 2025

2025-5-22
Посмотреть
EHA 2025 | GoBroad Medical Team Presents 24 Research Achievements on the Global Stage! Multi-Dimensional Innovations Break Therapeutic Boundaries and Enhance Patient Survival

2025-5-15
Посмотреть
Pioneering the introduction of groundbreaking medications, offering renewed hope to patients with relapse or refractory tumors.

2025-3-4
Посмотреть
Breaking Through Drug Resistance! Beijing GoBroad Hospital has Issued the First Prescription for Taletrectinib in Beijing, Bringing Renewed Hope for Advanced Lung Cancer Patients

2025-2-22
Посмотреть
China Pharmaceutical University and GoBroad Healthcare Group Establish the "Institute of Statistical Science" to Advance Biopharmaceutical Research and Clinical Innovation

2025-2-13
Посмотреть
The "Beijing Key Laboratory of Cell and Gene Therapy for Solid Tumors" headed by Prof. Shen Lin was successfully approved.

2025-2-7
Посмотреть
Successfully Passed the Review! Beijing GoBroad Hospital Has Obtained the Qualification for Clinical Application of Lu-177 Radionuclide Therapy

2024-12-10
Посмотреть
ASH2024丨17 achievements of GoBroad medical team highlight the international academic stage!

2024-11-1
Посмотреть

Свяжитесь с нами